| scholarly article | Q13442814 |
| P2093 | author name string | Sabrina Gill | |
| Karin H. Humphries | |||
| P2860 | cites work | HRT and Vit D in prevention of non-vertebral fractures in postmenopausal women; a 5 year randomized trial | Q74633398 |
| Treatment of estrogen deficiency symptoms in women surviving breast cancer. The Hormone Foundation, Canadian Breast Cancer Research Initiative, National Cancer Institute of Canada, Endocrine Society, and the University of Virginia Cancer Center and | Q74645825 | ||
| An evaluation of psychologic effects of sex hormone administration in aged women. I. Results of therapy after six months | Q76110185 | ||
| Meta-analysis of estrogen therapy in the management of urogenital atrophy in postmenopausal women: second report of the Hormones and Urogenital Therapy Committee*1 | Q77386006 | ||
| Estrogen and atherosclerosis | Q77522610 | ||
| Estrogen replacement therapy after localized breast cancer: clinical outcome of 319 women followed prospectively | Q77766566 | ||
| Hormone replacement therapy and cardiovascular disease: a statement for healthcare professionals from the American Heart Association | Q95721603 | ||
| Prediction of Coronary Heart Disease Using Risk Factor Categories | Q22241923 | ||
| Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial | Q27860743 | ||
| Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer | Q28142158 | ||
| Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II) | Q28193306 | ||
| Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) | Q29547825 | ||
| Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group | Q29615228 | ||
| Risk of breast cancer with progestins in combination with estrogen as hormone replacement therapy | Q30306945 | ||
| Postmenopausal estrogen replacement and risk for venous thromboembolism: a systematic review and meta-analysis for the U.S. Preventive Services Task Force | Q30703758 | ||
| Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group. | Q31921266 | ||
| Conjugated equine estrogen improves glycemic control and blood lipoproteins in postmenopausal women with type 2 diabetes | Q32086385 | ||
| Postmenopausal hormone replacement therapy: scientific review | Q33184140 | ||
| Effects of hormone replacement therapy in rheumatoid arthritis: a double blind placebo-controlled study | Q33566054 | ||
| Sex hormones and the risk of osteoarthritis in women: epidemiological evidence. | Q33579280 | ||
| The protective effects of estrogen on the cardiovascular system | Q33654314 | ||
| Androgen replacement in women: a commentary | Q33662602 | ||
| Estrogen replacement therapy and colon cancer: a clinical review | Q33792914 | ||
| Report of the international consensus development conference on female sexual dysfunction: definitions and classifications | Q33845358 | ||
| Hormone replacement therapy in postmenopausal women: endometrial hyperplasia and irregular bleeding | Q33909491 | ||
| Transdermal testosterone treatment in women with impaired sexual function after oophorectomy | Q33916725 | ||
| Fracture risk reduction with alendronate in women with osteoporosis: the Fracture Intervention Trial. FIT Research Group | Q33926440 | ||
| Is it time to stop teaching breast self-examination? | Q33956012 | ||
| Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National Osteoporosis Risk Assessment | Q34104308 | ||
| Estrogen and the risk of breast cancer | Q34137105 | ||
| Conseusus statements on prognostic factors in epithelial ovarian carcinoma. Report of the Consensus Meeting organized by the European Society of Gynaecological Oncology, ESGO. | Q34151279 | ||
| Hormone therapy to prevent disease and prolong life in postmenopausal women | Q34262585 | ||
| Hormone replacement therapy and prevention of nonvertebral fractures: a meta-analysis of randomized trials | Q34278918 | ||
| 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. | Q34300668 | ||
| A Meta-analysis of the Effect of Estrogen Replacement Therapy on the Risk of Breast Cancer | Q34747966 | ||
| Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence | Q34748119 | ||
| Meta-analyses of therapies for postmenopausal osteoporosis. V. Meta-analysis of the efficacy of hormone replacement therapy in treating and preventing osteoporosis in postmenopausal women | Q34803319 | ||
| Hormone replacement therapy and risk of venous thromboembolism: population based case-control study | Q36243429 | ||
| Events per person year--a dubious concept | Q36902438 | ||
| Symptom relief and side effects of postmenopausal hormones: results from the Postmenopausal Estrogen/Progestin Interventions Trial | Q39443195 | ||
| Oestrogen therapy and the menopausal syndrome | Q39582567 | ||
| Hormone replacement therapy and endometrial cancer risk: a meta-analysis | Q40571296 | ||
| Postmenopausal estrogen therapy and the risk for developing systemic lupus erythematosus | Q40593753 | ||
| The influence of oestrogens on the wellbeing and mental performance in climacteric and postmenopausal women | Q40806348 | ||
| Cardiovascular effects of estrogen and lipid-lowering therapies in postmenopausal women | Q40989431 | ||
| In vivo effects by estrone sulfate on the central nervous system-senile dementia (Alzheimer's type). | Q41256378 | ||
| Lifelong estrogen exposure and cognitive performance in elderly women | Q41618550 | ||
| Hormone replacement therapy in postmenopausal women with systemic lupus erythematosus | Q41698301 | ||
| A two-year, double-blind comparison of estrogen-androgen and conjugated estrogens in surgically menopausal women. Effects on bone mineral density, symptoms and lipid profiles. | Q41716499 | ||
| Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin | Q41719517 | ||
| Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). | Q42679385 | ||
| Effects of hormone replacement therapy on clinical fractures and height loss: The Heart and Estrogen/Progestin Replacement Study (HERS). | Q43593880 | ||
| Bone mineral density response to estrogen replacement in frail elderly women: a randomized controlled trial | Q43702649 | ||
| A Clinical Trial of Estrogen-Replacement Therapy after Ischemic Stroke | Q43779426 | ||
| Estrogen in the prevention of atherosclerosis. A randomized, double-blind, placebo-controlled trial | Q43813509 | ||
| Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators | Q43988923 | ||
| Treatment of postmenopausal osteoporosis with transdermal estrogen | Q44087639 | ||
| A study of hormone replacement therapy in postmenopausal women with ischaemic heart disease: the Papworth HRT atherosclerosis study | Q44147950 | ||
| Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: a randomized controlled trial | Q44218875 | ||
| Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk | Q44507925 | ||
| Menopause, postmenopausal estrogen preparations, and the risk of adult-onset asthma. A prospective cohort study | Q44514936 | ||
| Hormone replacement therapy in breast cancer survivors: a cohort study | Q46446899 | ||
| Estrogen improves psychological function in asymptomatic postmenopausal women | Q46492621 | ||
| Hormone replacement therapy, heart disease, and other considerations | Q46966284 | ||
| Observations in a preliminary open trial of estradiol therapy for senile dementia-Alzheimer's type | Q48395222 | ||
| Postmenopausal hormone use and cholecystectomy in a large prospective study | Q50184228 | ||
| Hormonal replacement therapy reduces forearm fracture incidence in recent postmenopausal women - results of the Danish Osteoporosis Prevention Study | Q50567905 | ||
| Reproductive risk factors in a prospective study of breast cancer: the Nurses' Health Study | Q50604204 | ||
| The role of hormone replacement therapy in the risk for breast cancer and total mortality in women with a family history of breast cancer | Q50627109 | ||
| Estrogen replacement therapy and ovarian cancer mortality in a large prospective study of US women | Q50672431 | ||
| Dehydroepiandrosterone replacement in women with adrenal insufficiency | Q51086224 | ||
| Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study | Q51952380 | ||
| Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women | Q52127221 | ||
| Effects of estrogen on memory function in surgically menopausal women | Q52229708 | ||
| Replacement therapy and piperazine oestrone sulphate ('Harmogen') and its effect on memory | Q52243867 | ||
| Estrogen deficiency: In search of symptom control and sexuality | Q53518278 | ||
| Estrogen replacement therapy in breast cancer survivors. A time for change. Breast Cancer Committees of the Eastern Cooperative Oncology Group | Q53658888 | ||
| Androgen Replacement in Women: A Commentary | Q56673397 | ||
| Oral, but Not Transdermal, Administration of Estrogens Lowers Tissue-Type Plasminogen Activator Levels in Humans Without Affecting Endothelial Synthesis | Q57338607 | ||
| Breast-cancer risk following long-term oestrogen- and oestrogen-progestin-replacement therapy | Q57549470 | ||
| Testosterone enhances estradiol's effects on postmenopausal bone density and sexuality | Q57990275 | ||
| The Women’s Health Initiative Memory Study (WHIMS) | Q63434960 | ||
| Breast cancer risk and duration of estrogen use: the role of study design in meta-analysis | Q64135382 | ||
| Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group | Q67979093 | ||
| Projecting individualized probabilities of developing breast cancer for white females who are being examined annually | Q69396132 | ||
| Hormone replacement therapy and risk of breast cancer: results from epidemiologic studies | Q70728804 | ||
| Evaluation of estrogen treatment in female patients with dementia of the Alzheimer type | Q70803658 | ||
| Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial | Q70918505 | ||
| Estrogen therapy, atherosclerosis, and clinical cardiovascular events | Q71691426 | ||
| Quantitative classification of mammographic densities and breast cancer risk: results from the Canadian National Breast Screening Study | Q72241677 | ||
| Sub-clinical worsening of bronchial asthma during estrogen replacement therapy in asthmatic post-menopausal women | Q72243395 | ||
| Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial | Q72375182 | ||
| Assessment and counseling for women with a family history of breast cancer. A guide for clinicians | Q72473284 | ||
| A comparison of esterified estrogens with and without methyltestosterone: effects on endometrial histology and serum lipoproteins in postmenopausal women | Q72587334 | ||
| Screening for factor V Leiden mutation before prescribing combination oral contraceptives | Q73082537 | ||
| Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial | Q73365346 | ||
| Increased risk of recurrent venous thromboembolism during hormone replacement therapy--results of the randomized, double-blind, placebo-controlled estrogen in venous thromboembolism trial (EVTET) | Q73387757 | ||
| Postmenopausal hormone therapy and risk of stroke: The Heart and Estrogen-progestin Replacement Study (HERS) | Q73395336 | ||
| A decision tree for the use of estrogen replacement therapy or hormone replacement therapy in postmenopausal women: consensus opinion of The North American Menopause Society | Q73622765 | ||
| Effects of oral and transdermal estrogen/progesterone regimens on blood coagulation and fibrinolysis in postmenopausal women. A randomized controlled trial | Q73965928 | ||
| Hormone replacement therapy and the risk of colorectal cancer: a meta-analysis | Q74059471 | ||
| Effects of estrogen replacement on the progression of coronary-artery atherosclerosis | Q74212886 | ||
| A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. PROOF Study Group | Q74341821 | ||
| A Four-Year Randomized Controlled Trial of Hormone Replacement and Bisphosphonate, Alone or in Combination, in Women with Postmenopausal Osteoporosis | Q74463864 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Hormone Replacement Therapy | Q108667313 |
| P1104 | number of pages | 10 | |
| P304 | page(s) | 1001-1010 | |
| P577 | publication date | 2003-04-01 | |
| 2003-04-15 | |||
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | Canadian Medical Association Journal | Q5030320 |
| P1476 | title | Risks and benefits of hormone replacement therapy: the evidence speaks | |
| P478 | volume | 168 |
| Q36038557 | Colorectal cancer: a case control study of dietary factors, king faisal specialist hospital and researh center, riyadh, saudi arabia |
| Q35152376 | Combination hormone replacement therapy and dementia |
| Q36516411 | Effect of hormone replacement therapy (HRT) on periodontal status of postmenopausal women |
| Q39726293 | Estrogen prevents sustained COLO-205 human colon cancer cell growth by inducing apoptosis, decreasing c-myb protein, and decreasing transcription of the anti-apoptotic protein bcl-2. |
| Q61800805 | Estrogenic Effect of the Extract of QingYan Formula on Reproductive Tissues in Immature Mice |
| Q36862676 | Estrogenic activities of Fatty acids and a sterol isolated from royal jelly |
| Q42796816 | Frederick Banting and the opportunities for research for general practitioners |
| Q34828432 | Frederick Banting and the opportunities of research by general practitioners |
| Q37213718 | Long-term efficacy and safety of anastrozole for adjuvant treatment of early breast cancer in postmenopausal women |
| Q42376243 | Protective effect of Rhus verniciflua Stokes extract in an experimental model of post-menopausal osteoporosis |
| Q36353581 | RETRACTED ARTICLE: Short-time QiBaoMeiRan Formula Treatment Exerts Estrogenic Activities without Side Effects on Reproductive Tissues in Immature Mice |
| Q37643507 | Salvia miltiorrhiza bunge increases estrogen level without side effects on reproductive tissues in immature/ovariectomized mice |
| Q34082037 | Treatment with qibaomeiran, a kidney-invigorating Chinese herbal formula, antagonizes estrogen decline in ovariectomized rats |
Search more.